Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides
Methods for selectively manipulating a growth rate of a selected bacterium comprising the step of contacting the selected bacterium with a predetermined amount of a quorum sensing molecule to affect a change in the growth rate of the selected bacterium, wherein the quorum sensing molecule is species specific, and the change in the growth rate is dependent on the amount of quorum sensing molecule in a dose-dependent fashion. Also provided are methods for treating or protecting against bacterial infections by utilizing the dose-dependent response of bacterial quorum sensing systems. The methods can be applied to a wide range of bacteria species including Streptococci, Staphylococci , and Bacilli . Compositions, medicaments and oral formulations for use with the methods are also disclosed.
1. A method for treating a condition associated with the attachment of Streptococcus mutans to teeth of a subject, comprising:
administering to the subject a composition comprising an orally acceptable carrier in combination with a competence stimulating peptide in an amount effective to inhibit the expression of at least one glucosyltransferase gene selected from the group consisting of gftB and gftC, thereby reducing the presence of Streptococcus mutans on the teeth of the subject,
wherein the effective amount is dependent on the level of reduction based on a dose-response relationship between a growth rate of Streptococcus mutans and the competence stimulating peptide, and
wherein the competence stimulating peptide comprises SEQ ID NO: 1.
2. The method of claim 1 , wherein the composition further comprises an anti-caries agent.
3. The method of claim 1 , wherein the composition is in the form of a mouthwash solution, an abrasive dentifrice gel, a chewing gum, a nonabrasive dentifrice gel, a nonabrasive gel composition, or a soft drink.
4. The method of claim 1 , wherein the condition is selected from a group consisting of dental caries and infective endocarditis.
5. The method of claim 2 , wherein the anti-caries agent is selected from the group consisting of water insoluble noncationic antimicrobial agents, non-steroidal anti-inflammatory drugs, fluoride reagents, histidine-rich polypeptides, casein, urea, calcium lactate, calcium glycerophosphate, non-immunogenic amino acid segments of proline-rich proteins, and monoclonal antibodies against Streptococcus mutans.
6. The method of claim 1 , further comprising the step of cleaning the teeth before the administering step.
7. The method of claim 1 , wherein the amount of the competence stimulating peptide is greater than 1 mg/ml.
8. The method of claim 1 , wherein the competence stimulating peptide is packaged in a hydrophobic delivery vehicle and the composition further comprises one or more competence stimulating peptide stabilizing agents.
9. The method of claim 8 , wherein the competence stimulating peptide stabilizing agents are selected from the group consisting of a detergent, a hydrophobic solvent, and combinations thereof.
10. A method for treating a condition associated with the attachment of Streptococcus mutans to teeth of a subject, comprising:
administering to the subject a composition comprising an orally acceptable carrier in combination with a competence stimulating peptide in an amount effective to reduce the presence of Streptococcus mutans on the teeth of the subject,
wherein the competence stimulating peptide comprises SEQ ID NO: 1.
11. The method of claim 10 , wherein the composition further comprises an anti-caries agent.
12. The method of claim 10 , wherein the composition is a mouthwash solution, an abrasive dentifrice gel, a chewing gum, a nonabrasive dentifrice gel, a nonabrasive gel composition, or a soft drink.
13. A method for treating a condition associated with the attachment of Streptococcus mutans to teeth of a subject, comprising:
administering to the subject a composition consisting essentially of an orally acceptable carrier in combination with a competence stimulating peptide in an amount effective to reduce the presence of Streptococcus mutans on teeth,
wherein the effective amount is dependent on the level of reduction based on a dose-response relationship between a growth rate of Streptococcus mutans and the competence stimulating peptide, and
wherein the competence stimulating peptide comprises SEQ ID NO: 1.
14. The method of claim 13 , wherein the composition further comprises an anti-caries agent.
15. The method of claim 13 , wherein the composition is in the form of a mouthwash solution, an abrasive dentifrice gel, a chewing gum, a nonabrasive dentifrice gel, a nonabrasive gel composition, or a soft drink.
16. The method of claim 13 , wherein the composition is in the form of a mouthwash solution, an abrasive dentifrice gel, a chewing gum, a nonabrasive dentifrice gel, a nonabrasive gel composition, or a soft drink.
17. The method of claim 13 , wherein the condition is selected from a group consisting of dental caries and infective endocarditis.
18. A method of inhibiting expression of at least one glucosyltransferase gene selected from the group consisting of gftB and gftC in Streptococcus Mutans comprising the step of contacting Streptococcus mutans with a competence stimulating peptide, wherein the competence stimulating peptide comprises SEQ ID NO: 1.